161 related articles for article (PubMed ID: 2013808)
41. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Haematologica; 2000 Jun; 85(6):613-8. PubMed ID: 10870118
[TBL] [Abstract][Full Text] [Related]
42. [On the diagnosis of malignant lymphoma from the lymphogram].
Trapp P; Feindt HR
Fortschr Geb Rontgenstr Nuklearmed; 1967 Sep; 107(3):336-44. PubMed ID: 4869958
[No Abstract] [Full Text] [Related]
43. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
44. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Goldberg MA; Lee MJ; Fischman AJ; Mueller PR; Alpert NM; Thrall JH
Radiographics; 1993 Sep; 13(5):1047-62. PubMed ID: 8210589
[TBL] [Abstract][Full Text] [Related]
45. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
46. [Diagnosis of energy metabolism in ENT tumors--a PET study].
Reisser C; Haberkorn U; Strauss LG
HNO; 1992 Jun; 40(6):225-31. PubMed ID: 1634382
[TBL] [Abstract][Full Text] [Related]
47. Metabolic imaging of human extremity musculoskeletal tumors by PET.
Kern KA; Brunetti A; Norton JA; Chang AE; Malawer M; Lack E; Finn RD; Rosenberg SA; Larson SM
J Nucl Med; 1988 Feb; 29(2):181-6. PubMed ID: 2831318
[TBL] [Abstract][Full Text] [Related]
48. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
[TBL] [Abstract][Full Text] [Related]
49. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen.
Stahl A; Weber WA; Avril N; Schwaiger M
Nuklearmedizin; 2000 Dec; 39(8):241-5. PubMed ID: 11189901
[TBL] [Abstract][Full Text] [Related]
50. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
Lowe VJ; Wiseman GA
J Nucl Med; 2002 Aug; 43(8):1028-30. PubMed ID: 12163627
[No Abstract] [Full Text] [Related]
51. Similar pelvic abnormalities on FDG positron emission tomography of different origins.
Zhuang H; Yamamoto AJ; Sinha P; Pourdehnad M; Liu Y; Alavi A
Clin Nucl Med; 2001 Jun; 26(6):515-7. PubMed ID: 11353298
[TBL] [Abstract][Full Text] [Related]
52. FDG-PET appearance of pelvic Castleman's disease.
Murphy SP; Nathan MA; Karwal MW
J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
[TBL] [Abstract][Full Text] [Related]
53. Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study.
Scott AM; Gunawardana DH; Wong J; Kirkwood I; Hicks RJ; Ho Shon I; Ramshaw JE; Robins P
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):347-53. PubMed ID: 18931840
[TBL] [Abstract][Full Text] [Related]
54. [Lymphangiography in the diagnosis of primary malignant lymphomas].
Beltz L
Dtsch Med Wochenschr; 1972 Jan; 97(4):124-5. PubMed ID: 4550710
[No Abstract] [Full Text] [Related]
55. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
56. Camera-based FDG PET and 67Ga SPECT in evaluation of lymphoma: comparative study.
Bar-Shalom R; Yefremov N; Haim N; Dann EJ; Epelbaum R; Keidar Z; Gaitini D; Frenkel A; Israel O
Radiology; 2003 May; 227(2):353-60. PubMed ID: 12637679
[TBL] [Abstract][Full Text] [Related]
57. Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.
Basu S; Mahne A; Iruvuri S; Alavi A
Clin Lymphoma Myeloma; 2007 Jan; 7(4):309-14. PubMed ID: 17324340
[TBL] [Abstract][Full Text] [Related]
58. Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration.
Chiang SB; Rebenstock A; Guan L; Burns J; Alavi A; Zhuang H
Clin Nucl Med; 2003 Sep; 28(9):786-8. PubMed ID: 12973012
[TBL] [Abstract][Full Text] [Related]
59. [Clinical evaluation of 67Ga-citrate scintigraphy in malignant lymphoma (author's transl)].
Nakayama C; Oshiumi Y; Morita K; Kamoi I; Ichiya Y; Hasuo K; Kawahira K; Matsuura K
Kaku Igaku; 1978 Aug; 15(5):651-9. PubMed ID: 364119
[No Abstract] [Full Text] [Related]
60. Intravascular large B-cell lymphoma with FDG accumulation in the lung lacking CT/(67)gallium scintigraphy abnormality.
Kitanaka A; Kubota Y; Imataki O; Ohnishi H; Fukumoto T; Kurokohchi K; Tanaka T
Hematol Oncol; 2009 Mar; 27(1):46-9. PubMed ID: 18819161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
